Drug prices likely to rise with tariffs on EU
Summary
The U.S. plans to add a new 15% tariff on drug imports from the European Union. This could lead to higher prices for American customers and affect how medicines are sourced and made, as many drugs currently come from Europe.Key Facts
- The U.S. will impose a 15% fee (tariff) on certain drug imports from Europe.
- Wall Street analysts predict this could cost the drug industry between $13 billion and $19 billion.
- Many U.S. drugs and ingredients come from European countries like Ireland, Denmark, and Germany.
- The tariff may not apply to some generic medicines, according to the European Union leadership.
- Major pharmaceutical companies, such as Pfizer and Johnson & Johnson, use Ireland as a key production hub.
- Negotiations between industry lobbyists and U.S. policymakers are expected to determine the impact.
- The industry is monitoring a separate U.S. investigation that could lead to more tariffs on drugs from China and India.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
